Research Alliance Corp. II Class A Common Stock
RACB
RACB was delisted on the 1st of December, 2022.
38 hedge funds and large institutions have $137M invested in Research Alliance Corp. II Class A Common Stock in 2021 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 12 reducing their positions, and 2 closing their positions.
0% more funds holding
Funds holding: 38 → 38 (0)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
6% less capital invested
Capital invested by funds: $147M → $137M (-$9.55M)
75% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 12
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HM
HealthCor Management
New York
|
+$3.42M |
| 2 |
Millennium Management
New York
|
+$255K |
| 3 |
D.E. Shaw & Co
New York
|
+$170K |
| 4 |
FTCM
First Trust Capital Management
Chicago,
Illinois
|
+$907 |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$401 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LGM
Logos Global Management
San Francisco,
California
|
-$2.11M |
| 2 |
QGA
Q Global Advisors
Fort Worth,
Texas
|
-$2.05M |
| 3 |
CL
CSS LLC
Chicago,
Illinois
|
-$575K |
| 4 |
GCL
Glazer Capital LLC
New York
|
-$461K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$314K |
RACB Hedge Fund Activity: Q2 2021 in Review
38 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in Research Alliance Corp. II Class A Common Stock (RACB) for Q2 2021, worth a combined $137M — down 6.5% from $147M a quarter earlier.
Fund positioning in RACB was balanced in Q2 2021: 2 funds opened new positions, 2 closed out, 3 added to existing stakes and 12 trimmed.
The largest buyer was HealthCor Management, adding an estimated $3.42M. The largest seller was Logos Global Management, cutting an estimated $2.11M.
- 38 institutional investors held Research Alliance Corp. II Class A Common Stock (RACB) as of Q2 2021, unchanged from Q1 2021.
- Funds reported $137M of Research Alliance Corp. II Class A Common Stock stock for Q2 2021, down 6.5% quarter-over-quarter.
- 2 funds opened new Research Alliance Corp. II Class A Common Stock positions in Q2 2021 and 2 closed out, a net change of 0 holders.
- The largest Research Alliance Corp. II Class A Common Stock buyer in Q2 2021 was HealthCor Management, an estimated $3.42M added.
- The largest Research Alliance Corp. II Class A Common Stock seller in Q2 2021 was Logos Global Management, an estimated $2.11M sold.
Based on aggregated 13F filings for Q2 2021.